A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00445172
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
135
Enrollment
INDUSTRY
Sponsor class
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
DRUG:
E0302 (mecobalamin)
Sponsor
Eisai Co., Ltd.